Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension

Clinical trial NCT07641296 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07641296
Sponsor: SpyGlass Pharma, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2026-07-31
Primary completion: 2027-02-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.